title: Long-lasting hyperpolarization underlies seizure reduction by low frequency deep brain electrical stimulation.
abstract: Mesial temporal lobe epilepsy (MTLE) is a common medically refractory neurological disease. Deep brain electrical stimulation (DBS) of grey matter has been used for MTLE with limited success. However, stimulation of a white matter tract connecting the hippocampi, the ventral hippocampal commissure (VHC), with low frequencies that simulate interictal discharges has shown promising results, with seizure reduction greater than 98% in bilateral hippocampi during stimulation and greater than 50% seizure reduction in bilateral hippocampi after treatment. A major hurdle to the implementation and optimization of this treatment is that the mechanisms of seizure reduction by low frequency electrical stimulation (LFS) are not known. The goal of this study is to understand how commissural fibre tract stimulation reduces bilateral hippocampal epileptic activity in an in vitro slice preparation containing bilateral hippocampi connected by the VHC. It is our hypothesis that electrical stimuli induce hyperpolarization lasting hundreds of milliseconds following each pulse which reduces spontaneous epileptic activity during each inter-stimulus interval (ISI). Stimulus-induced long-lasting-hyperpolarization (LLH) can be mediated by GABA(B) inhibitory post-synaptic potentials (IPSPs) or slow after-hyperpolarization (sAHP). To test the role of LLH in effective bilateral seizure reduction by fibre tract stimulation, we measured stimulus-induced hyperpolarization during LFS of the VHC using electrophysiology techniques. Antagonism of the GABA(B) IPSP and/or sAHP diminished stimulus-induced hyperpolarization concurrently with LFS efficacy (greater than 50% reduction). Blocking both the GABA(B) IPSP and sAHP simultaneously eliminated the effect of electrical stimulation on seizure reduction entirely. These data show that LFS of the VHC is an effective protocol for bilateral hippocampal seizure reduction and that its efficacy relies on the induction of long-lasting hyperpolarization mediated through GABA(B) IPSPs and sAHP. Based on this study, optimization of the timing of LFS and LFS-induced-LLH may lead to improved outcomes from DBS treatments for human epilepsy.
authors: D. M. Durand: Neural Engineering Center, Departments of Biomedical Engineering and Neurosciences, Case Western Reserve University, Cleveland, OH 44106, USA. dxd6@case.edu.
authors: Sheela
authors: S
authors: Toprani
authors: Dominique M
authors: DM
authors: Durand
mesh_terms: D000818:Animals; D046690:Deep Brain Stimulation / Q000379:methods; D004558:Electric Stimulation / Q000379:methods; D004599:Electric Stimulation Therapy / Q000379:methods; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy / Q000503:physiopathology* / Q000628:therapy*; D058788:GABA-B Receptor Antagonists / Q000494:pharmacology; D006624:Hippocampus / Q000187:drug effects / Q000503:physiopathology*; D053444:Inhibitory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology; D009457:Neuroglia / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012640:Seizures / Q000188:drug therapy / Q000503:physiopathology* / Q000628:therapy*
chemical_list: D058788:GABA-B Receptor Antagonists
references: J Neurosci. 2006 Apr 19;26(16):4216-27
references: 16624942
references: Epilepsia. 1995 Sep;36(9):905-10
references: 7649130
references: Epilepsia. 2005 Jan;46(1):1-7
references: 15660762
references: J Physiol. 1984 Sep;354:319-31
references: 6434729
references: Neuropharmacology. 2005 Mar;48(3):343-53
references: 15721166
references: Neurology. 2011 Sep 27;77(13):1295-304
references: 21917777
references: J Neurosci. 2000 Jan 15;20(2):783-90
references: 10632607
references: Learn Mem. 1998 Sep-Oct;5(4-5):257-73
references: 10454353
references: Curr Opin Neurol. 2006 Apr;19(2):164-8
references: 16538091
references: J Neurosci. 1997 Dec 1;17(23):9308-14
references: 9364076
references: Eur J Pharmacol. 1997 Aug 13;332(3):245-55
references: 9300256
references: C R Biol. 2005 Feb;328(2):177-86
references: 15771004
references: Neurotherapeutics. 2010 Oct;7(4):424-38
references: 20880506
references: J Physiol. 1987 Aug;389:187-203
references: 2445972
references: Lancet. 2006 Apr 1;367(9516):1087-1100
references: 16581409
references: Brain Res. 2009 Feb 19;1255:57-66
references: 19100724
references: Neurobiol Dis. 2005 Jun-Jul;19(1-2):119-28
references: 15837567
references: J Clin Neurophysiol. 1995 Jan;12(1):2-22
references: 7896906
references: Front Comput Neurosci. 2012 Oct 10;6:81
references: 23091457
references: J Neurophysiol. 2000 May;83(5):3183-7
references: 10805716
references: Epilepsia. 2005;46 Suppl 5:98-9
references: 15987261
references: Nat Med. 2005 Sep;11(9):973-81
references: 16116433
references: Annu Rev Physiol. 1997;59:483-504
references: 9074774
references: Prog Neurobiol. 2002 Apr;66(5):345-53
references: 12015199
references: Prog Brain Res. 1990;83:161-87
references: 2203097
references: PLoS Biol. 2010 Apr 13;8(4):e1000352
references: 20405049
references: Epilepsia. 2005 Feb;46(2):203-16
references: 15679501
references: Nature. 1988 Mar 10;332(6160):156-8
references: 2831457
references: Science. 1980 Dec 5;210(4474):1122-4
references: 7444438
references: Clin Neurophysiol. 2005 Jun;116(6):1291-9
references: 15978492
references: J Neurophysiol. 1992 Dec;68(6):2100-9
references: 1491260
references: Br J Pharmacol. 2000 Feb;129(4):627-30
references: 10683185
references: J Neural Eng. 2007 Jun;4(2):1-16
references: 17409475
references: J Neurophysiol. 1993 Oct;70(4):1281-99
references: 8283200
references: J Neurophysiol. 1992 Jan;67(1):227-35
references: 1348084
references: Br J Pharmacol. 2001 Feb;132(4):889-98
references: 11181430
references: Epilepsy Behav. 2010 Jan;17(1):6-22
references: 19926525
references: Adv Neurol. 2006;97:537-48
references: 16383161
references: Epilepsia. 2010 Sep;51(9):1745-53
references: 20659150
references: J Physiol. 1984 Nov;356:97-113
references: 6097680
references: J Neurophysiol. 1995 Feb;73(2):876-9
references: 7760143
references: Neuron. 1988 Sep;1(7):585-91
references: 2856099
references: Brain Res. 1980 Oct 27;200(1):195-200
references: 7417806
references: Curr Opin Neurobiol. 1998 Jun;8(3):321-9
references: 9687354
references: Clin Neurophysiol. 2004 Jun;115(6):1239-48
references: 15134690
references: J Neurosci. 1987 Oct;7(10):3306-16
references: 2822865
references: J Neurophysiol. 2007 Mar;97(3):1887-902
references: 17151229
references: Nature. 1995 Nov 2;378(6552):75-8
references: 7477292
references: J Neurophysiol. 1987 Jun;57(6):1911-24
references: 3037040
references: Biophys J. 2003 Jan;84(1):687-95
references: 12524321
references: J Physiol. 1987 Apr;385:733-59
references: 2443676
references: Lancet Neurol. 2004 Feb;3(2):111-8
references: 14747003
references: Neurosci Lett. 2002 Jun 21;326(1):61-3
references: 12052538
references: Seizure. 2006 Oct;15(7):520-7
references: 16908203
references: Prog Neurobiol. 2002 Oct;68(3):167-207
references: 12450487
references: Epilepsia. 2003 Jul;44(7):877-85
references: 12823569
references: Exp Neurol. 2009 Nov;220(1):57-70
references: 19660453
references: Epilepsia. 2000 Feb;41(2):158-69
references: 10691112
references: Eur J Neurosci. 2006 May;23(9):2330-8
references: 16706841
references: Mol Pharmacol. 2006 Nov;70(5):1494-502
references: 16877678
references: Life Sci. 1996;59(5-6):413-20
references: 8761329
references: Epilepsia. 2001;42 Suppl 3:2-4
references: 11520313
references: J Neurophysiol. 1999 Nov;82(5):2130-42
references: 10561393
references: Arch Med Res. 2000 May-Jun;31(3):316-28
references: 11036183
references: J Neurophysiol. 1980 Feb;43(2):409-19
references: 6247461
references: Mol Cell Neurosci. 2001 Jun;17(6):1059-70
references: 11414794
references: Neuromodulation. 2013 Mar-Apr;16(2):105-13
references: 22882360
references: Epilepsia. 1997;38 Suppl 9:S37-42
references: 9578544
references: Trends Neurosci. 1996 Apr;19(4):150-4
references: 8658599
references: Brain Res. 2004 Feb 13;998(1):56-64
references: 14725968
references: Epilepsia. 2002 Mar;43(3):219-27
references: 11906505
references: J Neurophysiol. 1999 Mar;81(3):1184-91
references: 10085345
references: J Neurochem. 1969 Apr;16(4):485-91
references: 4388774
references: Brain Res. 1982 Nov 4;250(2):291-9
references: 6129030
references: Clin Neurophysiol. 2006 Apr;117(4):781-8
references: 16458067
references: Ann Neurol. 2010 Feb;67(2):250-7
references: 20225290
references: Epilepsy Res. 2004 Apr-May;59(2-3):95-105
references: 15246114
references: Pharmacol Res. 1991 May;23(4):389-98
references: 1876577
references: Int J Neural Syst. 2012 Jun;22(3):1250006
references: 23627622
references: Eur J Neurosci. 1999 Feb;11(2):673-81
references: 10051768
references: J Physiol. 2001 Nov 1;536(Pt 3):809-23
references: 11691874
references: Neuron. 2001 Jul 19;31(1):47-58
references: 11498050
references: J Neurophysiol. 1991 Apr;65(4):771-85
references: 1675671
references: Neuron. 1996 Apr;16(4):815-23
references: 8607999
references: Epilepsy Behav. 2012 Aug;24(4):497-502
references: 22749027
references: Neuron. 2000 Mar;25(3):673-81
references: 10774734
references: Epilepsia. 1996 Sep;37(9):879-91
references: 8814102
references: Trends Pharmacol Sci. 2006 Dec;27(12):652-8
references: 17056128
references: Exp Neurol. 1989 May;104(2):155-61
references: 2651139
references: Exp Neurol. 2013 Feb;240:28-43
references: 23123405
references: J Neurosci. 2004 Apr 7;24(14):3537-42
references: 15071101
references: Epilepsia. 2007 Aug;48(8):1551-60
references: 17726798
references: Adv Neurol. 2006;97:17-25
references: 16383111
references: Curr Eye Res. 1997 Apr;16(4):359-64
references: 9134325
references: J Physiol. 1997 Oct 1;504 ( Pt 1):113-26
references: 9350623
references: Ann Neurol. 2002 Nov;52(5):556-65
references: 12402252
references: Epilepsia. 2012 Jan;53(1):147-56
references: 22150779